• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理学家与专家的一致性及乳腺导管原位癌分类方案的可重复性。

Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.

作者信息

Wells W A, Carney P A, Eliassen M S, Grove M R, Tosteson A N

机构信息

Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire, USA.

出版信息

Am J Surg Pathol. 2000 May;24(5):651-9. doi: 10.1097/00000478-200005000-00003.

DOI:10.1097/00000478-200005000-00003
PMID:10800983
Abstract

Several histologic classifications for breast ductal carcinoma in situ (DCIS) have been proposed. This study assessed the diagnostic agreement and reproducibility of three DCIS classifications (Holland [HL], modified Lagios [LA], and Van Nuys [VN]) by comparing the interpretations of pathologists without expertise in breast pathology with those of three breast pathology experts, each a proponent of one classification. Seven nonexpert pathologists in New Hampshire and three experts evaluated 40 slides of DCIS according to the three classifications. Twenty slides were reinterpreted by each nonexpert pathologist. Diagnostic accuracy (nonexperts compared with experts) and reproducibility were evaluated using inter- and intrarater techniques (kappa statistic). Final DCIS grade and nuclear grade were reported most accurately among nonexpert pathologists using HL (kappa = 0.53 and 0.49, respectively) compared with LA and VN (kappa = 0.29 and 0.35, respectively, for both classifications). An intermediate DCIS grade was assessed most accurately using HL and LA, and a high grade (group 3) was assessed most accurately using VN. Diagnostic reproducibility was highest using HL (kappa = 0.49). The VN interpretation of necrosis (present or absent) was reported more accurately than the LA criteria (extensive, focal, or absent; kappa = 0.59 and 0.45, respectively), but reproducibility of each was comparable (kappa = 0.48 and 0.46, respectively). Intrarater agreement was high overall. Comparing all three classifications, final DCIS grade was reported best using HL. Nuclear grade (cytodifferentiation) using HL and the presence or absence of necrosis were the criteria diagnosed most accurately and reproducibly. Establishing one internationally approved set of interpretive definitions, with acceptable accuracy and reproducibility among both pathologists with and without expertise in breast pathology interpretation, will assist researchers in evaluating treatment effectiveness and characterizing the natural history of DCIS breast lesions.

摘要

已经提出了几种乳腺导管原位癌(DCIS)的组织学分类方法。本研究通过比较非乳腺病理专业的病理学家与三位乳腺病理专家(分别支持一种分类方法)的解读,评估了三种DCIS分类方法(荷兰分类法[HL]、改良拉吉奥斯分类法[LA]和范努伊斯分类法[VN])的诊断一致性和可重复性。新罕布什尔州的七位非专家病理学家和三位专家根据这三种分类方法对40张DCIS切片进行了评估。每位非专家病理学家对20张切片进行了重新解读。使用评分者间和评分者内技术(kappa统计量)评估诊断准确性(非专家与专家比较)和可重复性。与LA和VN相比(两种分类方法的kappa分别为0.29和0.35),非专家病理学家使用HL时最终DCIS分级和核分级报告得最准确(kappa分别为0.53和0.49)。使用HL和LA时,中间DCIS分级评估得最准确,使用VN时,高级别(3组)评估得最准确。使用HL时诊断可重复性最高(kappa = 0.49)。VN对坏死(存在或不存在)的解读比LA标准(广泛、局灶或不存在;kappa分别为0.59和0.45)报告得更准确,但每种方法的可重复性相当(kappa分别为0.48和0.46)。评分者内一致性总体较高。比较所有三种分类方法,使用HL时最终DCIS分级报告得最好。使用HL的核分级(细胞分化)以及坏死的存在与否是诊断最准确且可重复的标准。建立一套国际认可的解释性定义,在有和没有乳腺病理解读专业知识的病理学家中都具有可接受的准确性和可重复性,将有助于研究人员评估治疗效果并描述DCIS乳腺病变的自然史。

相似文献

1
Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.病理学家与专家的一致性及乳腺导管原位癌分类方案的可重复性。
Am J Surg Pathol. 2000 May;24(5):651-9. doi: 10.1097/00000478-200005000-00003.
2
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.23名欧洲病理学家采用五种分类方法对乳腺导管原位癌进行分类所达到的一致性。欧盟乳腺筛查病理学工作组。
Hum Pathol. 1998 Oct;29(10):1056-62.
3
Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.基于网络调查的三种乳腺导管原位癌分类系统的可重复性研究。
Pathol Res Pract. 2010 Oct 15;206(10):705-11. doi: 10.1016/j.prp.2010.06.004. Epub 2010 Jul 21.
4
Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.乳腺导管原位癌病理学新分类方案的可重复性
J Clin Pathol. 1998 Jun;51(6):450-4. doi: 10.1136/jcp.51.6.450.
5
Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.乳腺导管原位癌:组织学亚型分析的可重复性
Hum Pathol. 1997 Aug;28(8):967-73. doi: 10.1016/s0046-8177(97)90013-7.
6
The diagnostic challenge of low-grade ductal carcinoma in situ.低级别导管原位癌的诊断挑战
Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.
7
A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.乳腺导管原位癌组织病理学诊断建议
Breast Cancer. 2000;7(4):321-5. doi: 10.1007/BF02966398.
8
The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).乳腺癌的临床行为可能在浸润前期(原位导管癌)就已确定。
Cancer. 1997 Nov 1;80(9):1740-5.
9
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.乳腺导管内增生性病变诊断与分类不一致的原因。欧盟乳腺筛查病理学工作组
Eur J Cancer. 2000 Sep;36(14):1769-72. doi: 10.1016/s0959-8049(00)00181-7.
10
A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.对六种现代乳腺导管原位癌(DCIS)分类的批判性评价:与相关浸润性癌分级的相关性
Histopathology. 1996 Nov;29(5):397-409. doi: 10.1046/j.1365-2559.1996.d01-513.x.

引用本文的文献

1
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.在一项大规模国际评分者间可靠性研究中,组织病理学导管原位癌特征的预后价值
Breast Cancer Res Treat. 2020 Oct;183(3):759-770. doi: 10.1007/s10549-020-05816-x. Epub 2020 Jul 30.
2
Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists.术前乳腺活检中经典小叶肿瘤(B3 病变)的观察者间可重复性:瑞士乳腺和妇科病理学家工作组的研究。
J Cancer Res Clin Oncol. 2020 Jun;146(6):1473-1478. doi: 10.1007/s00432-020-03195-w. Epub 2020 Mar 30.
3
Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?
乳腺导管原位癌(DCIS)分级——它有什么问题?
Pathol Oncol Res. 2020 Apr;26(2):665-671. doi: 10.1007/s12253-019-00760-8. Epub 2019 Nov 27.
4
The diagnostic challenge of low-grade ductal carcinoma in situ.低级别导管原位癌的诊断挑战
Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.
5
Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation.识别并处理乳腺病理诊断中感知到的一致性与实际一致性之间的差距。
Mod Pathol. 2016 Jul;29(7):717-26. doi: 10.1038/modpathol.2016.62. Epub 2016 Apr 8.
6
Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.乳腺导管原位癌的组织病理学分级:通过观察者内再现性分析对一项基于网络的调查进行验证
Diagn Pathol. 2015 Jul 10;10:93. doi: 10.1186/s13000-015-0320-2.
7
The Value of Ensari's Proposal in Evaluating the Mucosal Pathology of Childhood Celiac Disease: Old Classification versus New Version.恩萨里提案在评估儿童乳糜泻黏膜病理学中的价值:旧分类与新版本。
Balkan Med J. 2012 Sep;29(3):281-4. doi: 10.5152/balkanmedj.2012.016. Epub 2012 Sep 1.
8
Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.尿路上皮乳头状肿瘤的组织学分级:联合分级(双编号分级系统)对可重复性的影响。
Virchows Arch. 2011 Jun;458(6):659-64. doi: 10.1007/s00428-011-1072-3. Epub 2011 Apr 12.
9
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.初始导管原位癌诊断后生物标志物表达与后续肿瘤风险。
J Natl Cancer Inst. 2010 May 5;102(9):627-37. doi: 10.1093/jnci/djq101. Epub 2010 Apr 28.
10
Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?乳腺柱状细胞病变的病理诊断:是否存在可重复性问题?
J Clin Pathol. 2005 Jul;58(7):705-9. doi: 10.1136/jcp.2004.025239.